JPRN-UMIN000020283已完成未知
The role of TP53 gene analysis in EUS-guided FNA specimens for differential diagnosis of pancreatic ductal adenocarcinoma - TP53 gene analysis in pancreatic ductal adenocarcinoma
agoya City University Graduate School of Medical Sciences0 个研究点目标入组 160 人开始时间: 2015年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Case whom no consent is obtained.
研究者
相似试验
招募中
不适用
A tau PET study with 18F-THK5351 on neurodegenerative disorders patients.Patients who are suspected neurodegenerative disorders including Alzheimer disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, frontotemporal lobe degeneration, Parkinson's disease, dementia with Lewy bodies, and others including possibly tau positive, negative, and inconstant disorders.JPRN-UMIN000036956agoya City Rehabilitation Agency150
进行中（未招募）
1 期
The use of FES-PET imaging as a tool to detect a possible reversion of Estrogen Receptor (ER)-a status in patients with metastatic breast cancer HER2 + and ERa neg treated with trastuzumab + pertuzumab + taxane.Metastatic breast cancer HER2 + and ERa neg.MedDRA version: 20.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2018-001552-36-FRINSTITUT CLAUDIUS REGAUD33
招募中
1 期
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate CancerProstate CancerNCT04167969Memorial Sloan Kettering Cancer Center16
招募中
1 期
Diagnostic PET/CT (Positron Emission Tomography/Computed Tomography) examination with the radiotracer 68Ga-FAPI-46 to assess fibroblast activation and risk in solid tumorsEUCTR2022-003786-38-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS50
招募中
1 期
68Ga-FAPI-46 PET-CT for molecular assessment of fibroblast activation and risk assessment in solid tumors (FAPI Basket)CTIS2024-511659-17-00Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.100